Answers are grounded in this paper and cite their sources.
Antifibrinolytic therapy reduces bleeding and chest tube drainage output in cardiac surgical patients but is associated with potential side effects. Two phase-II studies with new compounds were terminated prematurely. There is increasing evidence of adverse side effects with tranexamic acid.
No takes yet. Share an insight, caveat, or question.
Koster et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: